American cutaneous leishmaniasis: Special features in diagnosis and therapy;Kutane amerikanische Leishmaniose: Besonderheiten der Diagnostik und Therapie

Deutsche Medizinische Wochenschrift

Volumn 128, Issue 40, 2003, Pages 2065-2068

  Bormann, G ^a   William, T ^a   Schulz, A ^b   Marsch, W ^a   Gaber, G ^a  

^a MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^b BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

STIBOGLUCONATE SODIUM;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CELL INFILTRATION; DERMIS; ENZYME BLOOD LEVEL; GASTROINTESTINAL SYMPTOM; GIANT CELL; GUATEMALA; HISTOPATHOLOGY; HUMAN; INGUINAL REGION; LEG PAIN; LEG ULCER; LEISHMANIA BRAZILIENSIS; LYMPH NODE; LYMPHADENITIS; LYMPHOCYTIC INFILTRATION; MALE; PARASITE CULTIVATION; PARASITE IDENTIFICATION; PLASMA CELL; POLYMERASE CHAIN REACTION; SKIN LEISHMANIASIS; TREATMENT OUTCOME; ULCER HEALING;

ADULT; ANIMALS; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; BIOPSY; DNA, PROTOZOAN; GENOTYPE; GUATEMALA; HUMANS; INJECTIONS, INTRAVENOUS; LEISHMANIA BRAZILIENSIS; LEISHMANIASIS, CUTANEOUS; MALE; POLYMERASE CHAIN REACTION; SKIN; TIME FACTORS; TRAVEL;

EID: 0142028680     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2003-42703     Document Type: Article

References (19)

1. Antal GM, Lukehart SA, Meheus AZ. The endemic treponematoses. Microbes Infect 2002; 4: 83-94
2. Aronson NE, Wortmann GW, Johnson SC et al. Safety and efficacy of intravenous sodium stibogluconate in the treatment of leishmaniasis: recent US Military experience. Clin Inf Dis 1998; 27: 1457-1464
3. Ashford RW. Leishmaniasis reservoirs and their significance in control. Clin Dermatol 1996; 14: 523-532
4. Berman JD. Treatment of New World cutaneous and mucosal leishmaniases. Clin Dermatol 1996; 14: 519-522
5. Burbach G, May J, Harms G, Bienzle U. Leishmaniosen. Dtsch Med Wochenschr 1999; 124: 88-93
6. Desjeux P. Leishmaniasis: public health aspects and control. Clin Dermatol 1996; 14: 417-423
7. Fischer C, Voss A, Engel J. Development status of miltefosine as first oral drug in visceral and cutaneous leishmaniasis. Med Microbiol Immunol 2001; 190: 85-87
8. Grevelink SA, Lerner EA. Leishmaniasis. J Am Acad Dermatol 1996; 34: 257-272
9. Harms G, Bienzle U. Leishmaniose. Stuttgart: Georg Thieme Verlag, In: Lang W, editor. Tropenmedizin in Klinik und Praxis. 1999: 37-53
10. Harms-Zwingenberger G, Bienzle U. Leishmaniosen-Importierte Krankheiten. Dt Ärztebl 2000; 97: A-2098-2101
11. Hepburn NC. Cutaneous leishmaniasis. Clin Exp Dermatol 2000; 25: 363-370
12. Hepburn NC, Siddique I, Howie AF, Beckett GJ, Hayes PC. Hepatotoxicity of sodium stibogluconat therapy for American cutaneous leishmaniasis. Trans Soc Trop Med Hyg 1994; 88: 453-455
13. Herwaldt B. Leishmaniasis. Lancet 1999; 354: 1191-1199
14. Herwaldt B, Berman JD. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am J Trop Med Hyg 1992; 46: 296-306
15. Meyerhoff S. US Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Clin Infect Dis 1999; 28: 42-48
16. Onuma H, Matsui C, Inoue K et al. A case of mucosal leishmaniasis: beneficial usage of polymerase chain reaction for diagnosis. Int J Dermatol 2001; 40: 765-767
17. Smith HR, Connor MP, Beer TW, Ashton RE. The use of polymerase chain reaction in New World cutaneous leishmaniasis. Br J Dermatol 1998; 139: 539-540
18. Uezato H, Hagiwara K, Hosowaka A et al. A preminary study aimed at the detection of Leishmania parasites in subjects with cutaneous leishmaniasis using polymerase chain reaction. J Dermatol 1998; 25: 290-298
19. Weigle KA, Labrada LA, Lozano C, Santrich C, Barker DC. PCR-based diagnosis of acute and chronic cutaneous leishmaniasis caused by Leishmania (Viannia). J Clin Microbiol 2002; 40: 601-606